Oxford BioDynamics' test shows high accuracy for CRC detection
OXFORD, UK - Oxford BioDynamics Plc (AIM: OBD), a biotechnology company, has announced the successful outcomes of a clinical study for its EpiSwitch® Colorectal No-Stool Test (NST), which has been ...
Oxford Mail1mon
Oxford blood test aiming to detect cancers at early stages
A new blood test developed by the University of Oxford is showing "real promise" in detecting multiple types of cancer in their earliest stages. The test, named TriOx, is powered by machine ...